Related references
Note: Only part of the references are listed.Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences
Maria Victoria Noya-Riobo et al.
EXPERIMENTAL NEUROLOGY (2023)
Examining the paradoxical effects of kratom: a narrative inquiry
Kirsten E. Smith et al.
FRONTIERS IN PHARMACOLOGY (2023)
Changes in the Point-of-Sale Among Vape Shops in Six US Metropolitan Areas Over Time, 2018-2021
Carla J. Berg et al.
NICOTINE & TOBACCO RESEARCH (2023)
Unlocking the potential of TRPV1 based siRNA therapeutics for the treatment of chemotherapy-induced neuropathic pain
Akhilesh et al.
LIFE SCIENCES (2022)
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger et al.
FRONTIERS IN PHARMACOLOGY (2022)
Kratom alkaloid mitragynine: Inhibition of chemotherapy-induced peripheral neuropathy in mice is dependent on sex and active adrenergic and opioid receptors
Daniel J. Farkas et al.
IBRO NEUROSCIENCE REPORTS (2022)
Kratom use categories and their associations with co-occurring substance use and mental health disorder symptoms during the COVID-19 pandemic
David Adzrago et al.
DRUG AND ALCOHOL DEPENDENCE (2022)
Interactive Effects of μ-Opioid and Adrenergic-α2 Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine
Samuel Obeng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2022)
Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study
Jonathan Schimmel et al.
ADDICTION (2021)
NEUROPATHIC PAIN: FROM MECHANISMS TO TREATMENT
Nanna Brix Finnerup et al.
PHYSIOLOGICAL REVIEWS (2021)
Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for μ-Opioid Receptor and Opioid-Like Behavioral Effects in Ratss
Samuel Obeng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)
Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors
Gleice K. Silva-Cardoso et al.
NEUROPHARMACOLOGY (2021)
Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
Guido Cavaletti et al.
NEUROTHERAPEUTICS (2021)
Past-Year Kratom Use in the US: Estimates From a Nationally Representative Sample
Joseph J. Palamar
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2021)
Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
Raquel Maria P. Campos et al.
FRONTIERS IN PHYSIOLOGY (2021)
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
David P. Finn et al.
PAIN (2021)
Oxaliplatin Depolarizes the IB4- Dorsal Root Ganglion Neurons to Drive the Development of Neuropathic Pain Through TRPM8 in Mice
Bin Wu et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Mitragynine (Kratom)-Induced Cognitive Impairments in Mice Resemble δ9-THC and Morphine Effects: Reversal by Cannabinoid CB1 Receptor Antagonism
Ismail Nurul Iman et al.
FRONTIERS IN PHARMACOLOGY (2021)
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Walter C. Prozialeck et al.
FRONTIERS IN PHARMACOLOGY (2021)
Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic
Albert Garcia-Romeu et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected lndole-Based Kratom Alkaloids
Samuel Obeng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism
Jeffery D. Foss et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Lysophospholipids Contribute to Oxaliplatin-Induced Acute Peripheral Pain
Vittoria Rimola et al.
JOURNAL OF NEUROSCIENCE (2020)
Prevalence and characteristics of self-reported kratom use in a representative US general population sample
Jordan R. Covvey et al.
JOURNAL OF ADDICTIVE DISEASES (2020)
u Kratom as a substitute for opioids: Results from an online survey
Marion A. Coe et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Risk of death associated with kratom use compared to opioids
Jack E. Henningfield et al.
PREVENTIVE MEDICINE (2019)
Kratom use and mental health: A systematic review
Marc T. Swogger et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy
Zachary A. Curry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity
Akiko Chukyo et al.
NEUROPEPTIDES (2018)
The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Andrew C. Kruegel et al.
NEUROPHARMACOLOGY (2018)
Etiology and Pharmacology of Neuropathic Pain
Sascha R. A. Alles et al.
PHARMACOLOGICAL REVIEWS (2018)
Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models
Willias Masocha
PAIN RESEARCH & MANAGEMENT (2018)
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence
Richard A. Slivicki et al.
BIOLOGICAL PSYCHIATRY (2018)
Cannabidiol's Upregulation of N-acyl Ethanolamines in the Central Nervous System Requires N-acyl Phosphatidyl Ethanolamine-Specific Phospholipase D
Emma Leishman et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons
Saikat Chakraborty et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Methods Used to Evaluate Pain Behaviors in Rodents
Jennifer R. Deuis et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Patterns of Kratom use and health impact in the US-Results from an online survey
Oliver Grundmann
DRUG AND ALCOHOL DEPENDENCE (2017)
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators
Andrew C. Kruegel et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Combined Effects of Bee Venom Acupuncture and Morphine on Oxaliplatin-Induced Neuropathic Pain in Mice
Woojin Kim et al.
TOXINS (2016)
Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
DE Moulin et al.
Pain Research & Management (2016)
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal
Liting Deng et al.
BIOLOGICAL PSYCHIATRY (2015)
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Nanna B. Finnerup et al.
LANCET NEUROLOGY (2015)
Analgesic Effects of Bee Venom Derived Phospholipase A2 in a Mouse Model of Oxaliplatin-Induced Neuropathic Pain
Dongxing Li et al.
TOXINS (2015)
CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain
Liting Deng et al.
MOLECULAR PHARMACOLOGY (2015)
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
Sara Jane Ward et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy
Iryna A. Khasabova et al.
PHARMACOLOGICAL RESEARCH (2014)
Orally Active Opioid μ/δ Dual Agonist MGM-16, a Derivative of the Indole Alkaloid Mitragynine, Exhibits Potent Antiallodynic Effect on Neuropathic Pain in Mice
Kenjiro Matsumoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Diluted Bee Venom Injection Reduces Ipsilateral Mechanical Allodynia in Oxaliplatin-Induced Neuropathic Mice
Seo-Yeon Yoon et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Orally Active Opioid Compounds from a Non-Poppy Source
Robert B. Raffa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment
Josee Guindon et al.
PHARMACOLOGICAL RESEARCH (2013)
Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy
Gema Vera et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Antinociceptive Action of Isolated Mitragynine from Mitragyna Speciosa through Activation of Opioid Receptor System
Abdul Rahman Shamima et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy
Iryna A. Khasabova et al.
JOURNAL OF NEUROSCIENCE (2012)
The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models
Antonio Caprioli et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice
Sara Jane Ward et al.
ANESTHESIA AND ANALGESIA (2011)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Pharmacological Characterization of a Novel Cannabinoid Ligand, MDA19, for Treatment of Neuropathic Pain
Jijun J. Xu et al.
ANESTHESIA AND ANALGESIA (2010)
Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies
Gerardo Gutierrez-Gutierrez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons
Uma Anand et al.
MOLECULAR PAIN (2010)
Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5′-guanidinonaltrindole-induced scratching models in mice: Behavioral and neuroanatomical evidence
Saadet Inan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Anti-Inflammatory and Antinociceptive Effects of Mitragyna speciosa Korth Methanolic Extract
W. M. Shaik Mossadeq et al.
MEDICAL PRINCIPLES AND PRACTICE (2009)
Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)
Edward W. Boyer et al.
ADDICTION (2008)
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
Sherry Wolf et al.
EUROPEAN JOURNAL OF CANCER (2008)
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J. Rahn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats
D Pascual et al.
PAIN (2005)
Antinociceptive effect of 7-hydroxymitragynine in mice:: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa
K Matsumoto et al.
LIFE SCIENCES (2004)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review
SL Collins et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
D Smart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)